We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IQVIA beat Q4 earnings and revenue estimates, delivering 9.6% EPS growth and 10.3% Y/Y revenue rise.
IQV posted segment gains: R&D and Technology & Analytics grew about 10%, while Contract Sales surged 18.6%.
IQVIA guided 2026 revenues at $17.15-$17.35B and reported $2B cash with $561M in Q4 free cash flow.
IQVIA Holdings Analytics Inc. (IQV - Free Report) has reported impressive fourth-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.
Adjusted earnings were $3.42 per share, surpassing the Zacks Consensus Estimate by a slight margin and gaining 9.6% on a year-over-year basis. Total revenues of $4.4 billion beat the consensus estimate by 2.8% and rose 10.3% from the year-ago quarter.
IQV stock lost 1.4% in a year compared with the industry’s 10.9% dip. However, the Zacks S&P 500 Composite rose 17.8% during the same period.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
The Research and Development segment’s revenues were $2.3 billion. It rose 9.9% from the year-ago quarter and 8.2% on a constant-currency basis and met the Zacks Consensus Estimate.
IQV generated $1.8 billion in revenues from the Technology and Analytics segment. The metric increased 9.8% year over year and 7.1% on a constant-currency basis, standing at par with the consensus estimate.
Contract Sales and Medical Solutions revenues increased 18.6% on a year-over-year basis to $210 million. It moved up 15.3% on a constant-currency basis. Revenues surpassed the consensus mark of $193.2 million.
IQV’s Robust Profitability & Solid Cash Flow
Adjusted EBITDA for the fourth quarter of 2025 was $1 billion, a 5% rise from the year-ago quarter.
The company exited the quarter with cash and cash equivalents of $2 billion compared with $1.8 billion in the preceding quarter. Long-term debt (less current portion) was $13.9 billion compared with $15 billion at the end of the third quarter of 2025.
Net cash generated from operating activities was $735 million and capital expenditure came in at $174 million. During the fourth quarter of 2025, IQV reported $561 million in free cash flow.
IQV’s 2026 Outlook
For 2026, IQVIA’s revenue outlook comes in at $17.15-$17.35 billion. The guided range is higher than the Zacks Consensus Estimate of $17.03 billion.
For EPS, management expects it to be within a range of $12.55-$12.85. The outlook is lower than the consensus estimate of $12.93. IQVIA’s adjusted EBITDA view is kept at $3.98-$4.03 billion.
Equifax Inc. (EFX - Free Report) has reported impressive fourth-quarter 2025 results.
EFX posted $2.09 in EPS, beating the Zacks Consensus Estimate by 2.2%. This marked a 1.4% dip from the fourth quarter of 2025. The company recorded $1.6 billion in its top line, surpassing the consensus estimate by 1.3%. Revenues spiked 9.1% from the year-ago quarter’s actual.
Gartner, Inc. (IT - Free Report) has reported fourth-quarter 2025 results.
The company’s adjusted earnings per share of $3.94 beat the Zacks Consensus Estimate by 12.6% but decreased 27.7% from the year-ago quarter. Revenues of $1.8 billion beat the consensus estimate by a slight margin and improved 2.2% year over year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y
Key Takeaways
IQVIA Holdings Analytics Inc. (IQV - Free Report) has reported impressive fourth-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.
Adjusted earnings were $3.42 per share, surpassing the Zacks Consensus Estimate by a slight margin and gaining 9.6% on a year-over-year basis. Total revenues of $4.4 billion beat the consensus estimate by 2.8% and rose 10.3% from the year-ago quarter.
IQV stock lost 1.4% in a year compared with the industry’s 10.9% dip. However, the Zacks S&P 500 Composite rose 17.8% during the same period.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote
IQVIA’s Strong Segmental Growth in Q4
The Research and Development segment’s revenues were $2.3 billion. It rose 9.9% from the year-ago quarter and 8.2% on a constant-currency basis and met the Zacks Consensus Estimate.
IQV generated $1.8 billion in revenues from the Technology and Analytics segment. The metric increased 9.8% year over year and 7.1% on a constant-currency basis, standing at par with the consensus estimate.
Contract Sales and Medical Solutions revenues increased 18.6% on a year-over-year basis to $210 million. It moved up 15.3% on a constant-currency basis. Revenues surpassed the consensus mark of $193.2 million.
IQV’s Robust Profitability & Solid Cash Flow
Adjusted EBITDA for the fourth quarter of 2025 was $1 billion, a 5% rise from the year-ago quarter.
The company exited the quarter with cash and cash equivalents of $2 billion compared with $1.8 billion in the preceding quarter. Long-term debt (less current portion) was $13.9 billion compared with $15 billion at the end of the third quarter of 2025.
Net cash generated from operating activities was $735 million and capital expenditure came in at $174 million. During the fourth quarter of 2025, IQV reported $561 million in free cash flow.
IQV’s 2026 Outlook
For 2026, IQVIA’s revenue outlook comes in at $17.15-$17.35 billion. The guided range is higher than the Zacks Consensus Estimate of $17.03 billion.
For EPS, management expects it to be within a range of $12.55-$12.85. The outlook is lower than the consensus estimate of $12.93. IQVIA’s adjusted EBITDA view is kept at $3.98-$4.03 billion.
IQV carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshot
Equifax Inc. (EFX - Free Report) has reported impressive fourth-quarter 2025 results.
EFX posted $2.09 in EPS, beating the Zacks Consensus Estimate by 2.2%. This marked a 1.4% dip from the fourth quarter of 2025. The company recorded $1.6 billion in its top line, surpassing the consensus estimate by 1.3%. Revenues spiked 9.1% from the year-ago quarter’s actual.
Gartner, Inc. (IT - Free Report) has reported fourth-quarter 2025 results.
The company’s adjusted earnings per share of $3.94 beat the Zacks Consensus Estimate by 12.6% but decreased 27.7% from the year-ago quarter. Revenues of $1.8 billion beat the consensus estimate by a slight margin and improved 2.2% year over year.